80th Atom

Over the past 25+ years, Adam Michael founder of 80th Atom has helped 100s of life science companies to raise capital and establish commercial partnerships. 80th Atom develops bespoke communications programmes supporting its clients to access capital, establish and progress relationships with commercial partners, gain access to and influence KOLs, all through building strong credible brands. Adam Michael's experience in the sector covers drug development, medtech, and diagnostics, from academic spin-outs to multinational corporations. He has operated throughout the industry, within the media, financial services, business development, KOL engagement and patient recruitment. This broad understanding and experience of the sector enables 80th Atom to anticipate its clients' near and long-term requirements, and provide strategic access to the full-scope of communications channels open to them.